Small Company Offering and Sale of Securities Without Registration (d)
December 21 2021 - 3:53PM
Edgar (US Regulatory)
x
NoneEntity Type | 0001574232 | |
x
Corporation
o
Limited Partnership
o
Limited Liability Company
o
General Partnership
o
Business Trust
o
Other |
| Name of Issuer |
Addex Therapeutics Ltd. |
| Jurisdiction of Incorporation/Organization |
| SWITZERLAND |
| |
| Year of Incorporation/Organization |
| |
x
| Over Five Years Ago |
| |
o
| Within Last Five Years (Specify Year) | |
| |
o
| Yet to Be Formed | |
| 2. Principal Place of Business and Contact Information |
| Name of Issuer | |
| Addex Therapeutics Ltd. | |
| Street Address 1 | Street Address 2 |
| CHEMIN DES MINES 9 | |
| City | State/Province/Country | ZIP/Postal Code | Phone No. of Issuer |
| GENEVA | SWITZERLAND | CH-1202 | 01141228841555 |
| Last Name | First Name | Middle Name |
| Dyer | Timothy | |
| Street Address 1 | Street Address 2 |
| c/o Addex Therapeutics Ltd. | Chemin des Mines 9 |
| City | State/Province/Country | ZIP/Postal Code |
| Geneva | SWITZERLAND | CH-1202 |
| Relationship: |
x
| Executive Officer |
x
| Director |
o
| Promoter |
| Clarification of Response (if Necessary) |
| | |
| Last Name | First Name | Middle Name |
| Mills | Roger | |
| Street Address 1 | Street Address 2 |
| c/o Addex Therapeutics Ltd. | Chemin des Mines 9 |
| City | State/Province/Country | ZIP/Postal Code |
| Geneva | SWITZERLAND | CH-1202 |
| Relationship: |
x
| Executive Officer |
x
| Director |
o
| Promoter |
| Clarification of Response (if Necessary) |
| | |
| Last Name | First Name | Middle Name |
| Lutjens | Robert | |
| Street Address 1 | Street Address 2 |
| c/o Addex Therapeutics Ltd. | Chemin des Mines 9 |
| City | State/Province/Country | ZIP/Postal Code |
| Geneva | SWITZERLAND | CH-1202 |
| Relationship: |
x
| Executive Officer |
o
| Director |
o
| Promoter |
| Clarification of Response (if Necessary) |
| | |
| Last Name | First Name | Middle Name |
| Rocher | Jean-Philippe | |
| Street Address 1 | Street Address 2 |
| c/o Addex Therapeutics Ltd. | Chemin des Mines 9 |
| City | State/Province/Country | ZIP/Postal Code |
| Geneva | SWITZERLAND | CH-1202 |
| Relationship: |
x
| Executive Officer |
o
| Director |
o
| Promoter |
| Clarification of Response (if Necessary) |
| | |
| Last Name | First Name | Middle Name |
| Kalinichev | Mikhail | |
| Street Address 1 | Street Address 2 |
| c/o Addex Therapeutics Ltd. | Chemin des Mines 9 |
| City | State/Province/Country | ZIP/Postal Code |
| Geneva | SWITZERLAND | CH-1202 |
| Relationship: |
x
| Executive Officer |
o
| Director |
o
| Promoter |
| Clarification of Response (if Necessary) |
| | |
| Last Name | First Name | Middle Name |
| Lawton | Vincent | |
| Street Address 1 | Street Address 2 |
| c/o Addex Therapeutics Ltd. | Chemin des Mines 9 |
| City | State/Province/Country | ZIP/Postal Code |
| Geneva | SWITZERLAND | CH-1202 |
| Relationship: |
o
| Executive Officer |
x
| Director |
o
| Promoter |
| Clarification of Response (if Necessary) |
| | |
| Last Name | First Name | Middle Name |
| Nunn | Jake | |
| Street Address 1 | Street Address 2 |
| c/o NEA Enterprise Associates | 2855 Sand Hill Road |
| City | State/Province/Country | ZIP/Postal Code |
| Menlo Park | CALIFORNIA | 94025 |
| Relationship: |
o
| Executive Officer |
x
| Director |
o
| Promoter |
| Clarification of Response (if Necessary) |
| | |
| Last Name | First Name | Middle Name |
| Hill | Raymond | |
| Street Address 1 | Street Address 2 |
| c/o AddexTherapeutics Ltd. | Chemin des Mines 9 |
| City | State/Province/Country | ZIP/Postal Code |
| Geneva | SWITZERLAND | CH-1202 |
| Relationship: |
o
| Executive Officer |
x
| Director |
o
| Promoter |
| Clarification of Response (if Necessary) |
| | |
| Last Name | First Name | Middle Name |
| Manke | Isaac | |
| Street Address 1 | Street Address 2 |
| c/o Acorn Bioventures | 420 Lexington Avenue, Suite 2626 |
| City | State/Province/Country | ZIP/Postal Code |
| New York | NEW YORK | 10170 |
| Relationship: |
o
| Executive Officer |
x
| Director |
o
| Promoter |
| Clarification of Response (if Necessary) |
| | |
|
o
| Agriculture | | Health Care |
o
| Retailing |
| | Banking & Financial Services | |
x
| Biotechnology |
o
| Restaurants |
| |
o
| Commercial Banking | |
o
| Health Insurance | | Technology |
| |
o
| Insurance | |
o
| Hospitals & Physicians | |
o
| Computers |
| |
o
| Investing | |
o
| Pharmaceuticals | |
o
| Telecommunications |
| |
o
| Investment Banking | |
o
| Other Health Care | |
o
| Other Technology |
| |
o
| Pooled Investment Fund
| | | | | Travel |
| |
o
| Other Banking & Financial Services |
o
| Manufacturing | |
o
| Airlines & Airports |
| | Real Estate | |
o
| Lodging & Conventions |
| |
o
| Commercial | |
o
| Tourism & Travel Services |
| |
o
| Construction | |
o
| Other Travel |
| |
o
| REITS & Finance |
o
| Other |
| |
o
| Residential | |
| |
o
| Other Real Estate | |
|
o
| Business Services | |
| | Energy | |
| |
o
| Coal Mining | |
| |
o
| Electric Utilities | |
| |
o
| Energy Conservation | |
| |
o
| Environmental Services | |
| |
o
| Oil & Gas | |
| |
o
| Other Energy | |
| Revenue Range | Aggregate Net Asset Value Range |
|
o
| No Revenues |
o
| No Aggregate Net Asset Value |
|
o
| $1 - $1,000,000 |
o
| $1 - $5,000,000 |
|
o
| $1,000,001 - $5,000,000 |
o
| $5,000,001 - $25,000,000 |
|
o
| $5,000,001 - $25,000,000 |
o
| $25,000,001 - $50,000,000 |
|
o
| $25,000,001 - $100,000,000 |
o
| $50,000,001 - $100,000,000 |
|
o
| Over $100,000,000 |
o
| Over $100,000,000 |
|
x
| Decline to Disclose |
o
| Decline to Disclose |
|
o
| Not Applicable |
o
| Not Applicable |
| 6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply) |
|
o
| Rule 504(b)(1) (not (i), (ii) or (iii)) |
o
| Rule 505 |
|
o
| Rule 504 (b)(1)(i) |
x
| Rule 506(b) |
|
o
| Rule 504 (b)(1)(ii) |
o
| Rule 506(c) |
|
o
| Rule 504 (b)(1)(iii) |
o
| Securities Act Section 4(a)(5) |
| |
o
| Investment Company Act Section 3(c) |
|
x
| New Notice | Date of First Sale | 2021-12-21 |
o
| First Sale Yet to Occur |
| Does the Issuer intend this offering to last more than one year? |
o
| Yes |
x
| No |
| 9. Type(s) of Securities Offered (select all that apply) |
|
o
| Pooled Investment Fund Interests |
o
| Equity |
|
o
| Tenant-in-Common Securities |
o
| Debt |
|
o
| Mineral Property Securities |
x
| Option, Warrant or Other Right to Acquire Another Security |
|
x
| Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security |
o
| Other (describe) |
| | |
| 10. Business Combination Transaction |
| Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? |
o
| Yes |
x
| No |
| |
| Clarification of Response (if Necessary) | |
| |
| Minimum investment accepted from any outside investor | $ 0 USD |
| Recipient | Recipient CRD Number |
o
| None |
| H.C. Wainwright & Co., LLC | 375 |
| (Associated) Broker or Dealer |
x
| None | (Associated) Broker or Dealer CRD Number |
x
| None |
| | |
| Street Address 1 | Street Address 2 |
| 430 Park Avenue | |
| City | State/Province/Country | ZIP/Postal Code |
| New York | NEW YORK | 10022 |
| State(s) of Solicitation |
o
| All States |
o
| Foreign/Non-US |
NEW YORK
|
| 13. Offering and Sales Amounts |
| Total Offering Amount | $ 5935118 USD |
o
Indefinite |
| Total Amount Sold | $ 5935118 USD | |
| Total Remaining to be Sold | $ 0 USD |
o
Indefinite |
| |
| Clarification of Response (if Necessary) |
| Represents amounts receivable upon full-exercise of warrants to purchase ADS; such warrants have not yet been exercised. |
|
o
| Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
| |
| | Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: | 1 |
| 15. Sales Commissions & Finders’ Fees Expenses |
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
|
| Sales Commissions | $ 400620 USD |
o
| Estimate |
| Finders' Fees | $ 0 USD |
o
| Estimate |
| |
| Clarification of Response (if Necessary) |
| Represents amount receivable upon full-exercise of warrants to purchase ADS; such warrants have not yet been exercised. |
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
|
| | $ 0 USD |
o
Addex Therapeutics (NASDAQ:ADXN) Historical Stock Chart From Sep 2024 to Oct 2024
Addex Therapeutics (NASDAQ:ADXN) Historical Stock Chart From Oct 2023 to Oct 2024
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|